Literature DB >> 8866805

Campylobacter bacteremia in children.

R P Reed1, I R Friedland, F O Wegerhoff, M Khoosal.   

Abstract

OBJECTIVE: To describe clinical and laboratory data for, and to propose pathogenesis and management of, children from impoverished communities with Campylobacter bacteremia.
METHODS: A retrospective review of patient data generated from laboratory records in an urban tertiary care hospital in Soweto and a rural mission hospital in Eastern Transvaal, South Africa. Participants were 19 children presenting to either hospital with Campylobacter bacteremia. Clinical and laboratory data were collated.
RESULTS: Nineteen children with Campylobacter bacteremia were identified; all isolates were Campylobacter jejuni. Sixteen (84%) had malnutrition; 13 of these were severely malnourished. Thirteen (68%) were febrile at the time of bacteremia. Four children (21%) did not have diarrhea. The case fatality rate was 16% and may not have been influenced by aminoglycoside administration.
CONCLUSION: Malnourished children may be more likely to have gastrointestinal C. jejuni infection. Immunodeficiency and intestinal mucosal compromise secondary to malnutrition may render such children at increased risk of C. jejuni bacteremia and its consequences. C. jejuni bacteremia is potentially life-threatening and should be managed accordingly.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866805     DOI: 10.1097/00006454-199604000-00012

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

Review 1.  Campylobacter bacteremia: a rare and under-reported event?

Authors:  R Louwen; P van Baarlen; A H M van Vliet; A van Belkum; J P Hays; H P Endtz
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-03-17

2.  Disseminated zygomycosis due to Rhizopus schipperae after heatstroke.

Authors:  G M Anstead; D A Sutton; E H Thompson; I Weitzman; R A Otto; S K Ahuja
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

3.  Epidermal growth factor inhibits Campylobacter jejuni-induced claudin-4 disruption, loss of epithelial barrier function, and Escherichia coli translocation.

Authors:  Jennifer M Lamb-Rosteski; Lisa D Kalischuk; G Douglas Inglis; Andre G Buret
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

4.  A nationwide study of Campylobacter jejuni and Campylobacter coli bacteremia in Finland over a 10-year period, 1998-2007, with special reference to clinical characteristics and antimicrobial susceptibility.

Authors:  Benjamin Feodoroff; Anneli Lauhio; Patrik Ellström; Hilpi Rautelin
Journal:  Clin Infect Dis       Date:  2011-10       Impact factor: 9.079

5.  Antibiotic Resistance of Campylobacter Species in a Pediatric Cohort Study.

Authors:  Francesca Schiaffino; Josh M Colston; Maribel Paredes-Olortegui; Ruthly François; Nora Pisanic; Rosa Burga; Pablo Peñataro-Yori; Margaret N Kosek
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

6.  Local accessory gene sharing among Egyptian Campylobacter potentially promotes the spread of antimicrobial resistance.

Authors:  Shaimaa F Mouftah; Ben Pascoe; Jessica K Calland; Evangelos Mourkas; Naomi Tonkin; Charlotte Lefevre; Danielle Deuker; Sunny Smith; Harry Wickenden; Matthew D Hitchings; Samuel K Sheppard; Mohamed Elhadidy
Journal:  Microb Genom       Date:  2022-06

7.  Symptomatic and asymptomatic Campylobacter infections associated with reduced growth in Peruvian children.

Authors:  Gwenyth Lee; William Pan; Pablo Peñataro Yori; Maribel Paredes Olortegui; Drake Tilley; Michael Gregory; Richard Oberhelman; Rosa Burga; Cesar Banda Chavez; Margaret Kosek
Journal:  PLoS Negl Trop Dis       Date:  2013-01-31

8.  Comparative genomics and genome biology of invasive Campylobacter jejuni.

Authors:  C P A Skarp; O Akinrinade; A J E Nilsson; P Ellström; S Myllykangas; H Rautelin
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379

9.  Bioengineering of LAB vector expressing Haemolysin co-regulated protein (Hcp): a strategic approach to control gut colonization of Campylobacter jejuni in a murine model.

Authors:  Chandan Gorain; Afruja Khan; Ankita Singh; Samiran Mondal; Amirul Islam Mallick
Journal:  Gut Pathog       Date:  2021-07-30       Impact factor: 4.181

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.